TSXV/BONE (TSXV/BONE)

TSX Venture Exchange: TSXV/BONE · CAD

CA$0.04

+0.01 (+16.7%)· Recorded snapshot

Market cap	10.5M
Net income (ttm)	-1.3M
EPS (ttm)	-CA$0.01
Shares out	298.7M
Volume	150,885
Beta	-0.37

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -1.3M
EPS (ttm): -CA$0.01
Market cap: 10.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-11.2

P25 n/aP50 n/aP75 n/a

ROIC-6.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSXV/BONE indicators

Market & fundamental data

Available fields

160

Groups with data

Currency

CAD

Showing 160 of 160 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-04
Enterprise value	CAD 9.6M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-03-31
First seen	2026-05-10
Fiscal year end	June
Founded	1993
Industry	Other Industrial Metals & Mining
Is primary listing	Yes
ISIN number	CA10002E1060
Last earnings date	2025-10-28
Last refreshed	2026-10-30
Last stock split date	2017-08-30
Last stock split type	Reverse
Market cap	CAD 10.5M
Next earnings date	2026-11-04
Price	CAD 0.04
Price currency	CAD
Sector	Materials
SIC code	1000
Stock price date	2026-10-30
Symbol	tsxv/BONE
Website	https://boronone.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-14.45%
FCF / EV yield	-20.49%
FCF yield	-18.48%
Industry forward P/E	164.52x
P/B ratio	0.73x
Price / tangible book value	0.73x
Sector forward P/E	14.81x
Sector P/E	21.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-6.63%
ROA (5Y)	-5.37%
ROCE	-10.36%
ROE	-11.23%
ROE (5Y)	-10.2%
ROIC	-6.84%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -452,602
Depreciation and amortization	CAD 23,204
EBIT	CAD -1.3M
EBITDA	CAD -1.3M
EPS	CAD -0.01
FCF per share	CAD -0.01
Financing cash flow	CAD 2.6M
Free cash flow	CAD -1.7M
Free cash flow minus SBC	CAD -1.9M
Investing cash flow	CAD -452,602
Net borrowing	CAD -29,427
Net cash flow	CAD 934,038
Net income	CAD -1.3M
Operating cash flow minus SBC	CAD -1.5M
Operating income	CAD -1.3M
Stock-based compensation	CAD 251,088

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD 0.04
Debt / equity	0.01
Interest coverage	-71.96
Long-term assets	CAD 12.6M
Long-term liabilities	CAD -18,692
Net cash (debt)	CAD 882,281
Net cash / market cap	9.85%
Net debt / equity	-0.07
Piotroski F-Score	3
Property, plant and equipment	CAD 11.4M
Shareholders' equity	CAD 12.3M
Tangible book value	CAD 12.3M
Tangible book value per share	CAD 0.04
Total assets	CAD 12.7M
Total cash	CAD 1M
Total debt	CAD 151,014
Total liabilities	CAD 452,067
WACC	2.32%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 102,078
Current liabilities	CAD 470,759
Current ratio	2.61
Net working capital	CAD -176,551
Quick ratio	2.38
Working capital	CAD 714,521

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-13.57%
Shareholder yield	-13.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-92.21%
10Y return CAGR	-22.53%
10Y total return	-92.21%
150-day SMA	CAD 0.04
15Y price change	-96.43%
15Y return CAGR	-19.92%
15Y total return	-96.43%
1D price change	16.67%
1W price change	-14.29%
1W total return	-14.29%
1Y price change	-57.14%
1Y return CAGR	-57.17%
1Y total return	-57.14%
20-day SMA	CAD 0.03
200-day SMA	CAD 0.04
20Y price change	-96.7%
20Y return CAGR	-15.69%
20Y total return	-96.7%
3M price change	-25%
3M total return	-25%
3Y price change	-33.33%
3Y return CAGR	-12.64%
3Y total return	-33.33%
50-day SMA	CAD 0.03
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.09
52-week high date	2025-11-04
52-week low	CAD 0.03
52-week low date	2026-10-23
5Y price change	-70%
5Y return CAGR	-21.4%
5Y total return	-70%
6M price change	-14.29%
6M total return	-14.29%
All-time high	CAD 34.30
All-time high date	1997-02-14
All-time low	CAD 0.03
All-time low date	2020-03-18
Average true range (ATR)	CAD 0.00
Average volume	122.1K
Beta (1Y)	1.47
Beta (2Y)	1.37
Beta (5Y)	-0.37
Change from 52-week high	-58.82%
Change from 52-week low	40%
Change from all-time high	-99.91%
Change from all-time low	20%
Change from open	16.67%
Day's gap	0%
Dollar volume	CAD 5,281
High price	CAD 0.04
Low price	CAD 0.03
Monthly RSI	41.13
Open price	CAD 0.03
Position in 52-week range	100%
Previous close	CAD 0.03
Price vs 150-day SMA	-24.62%
Price vs 20-day SMA	-4.76%
Price vs 200-day SMA	-30.39%
Price vs 50-day SMA	-13.79%
Relative volume	1.24
RSI	42.77
Sharpe ratio	0.61
Sharpe ratio (3Y)	0.68
Sharpe ratio (5Y)	0.7
Sortino ratio	0.99
Sortino ratio (3Y)	1.11
Sortino ratio (5Y)	1.16
Volume	150.9K
Weekly RSI	39.25
YTD price change	-33.33%
YTD total return	-33.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	283.4M
Shares change (QoQ)	2.55%
Shares change (YoY)	13.57%
Shares held by insiders	5.1%
Shares outstanding	298.7M

Deeper analysis on TSXV/BONE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/BONE report

Is a complete TSXV/BONE research report available?

No complete published report is available for tsxv/BONE (TSXV/BONE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/BONE (TSXV/BONE)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/BONE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/BONE indicators

Profile and market data

Valuation

Profitability

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/BONE

Frequently asked questions